Table 6.
AZT | DOXY | |
---|---|---|
1st follow-up (no treat./tot) | 43/52 | 14/51 |
Switched patients | 9 | 37 |
2nd follow-up (no treat./tot) | 57/80 | 9/23 |
Retreated patients | 23 | 14 |
3rd follow-up (no treat./tot) | 77/80 | 8/23 |
No improvement | 3 | 15 |
The table shows group survival rate for each group since the beginning of the study, considering the actual number of patients at any follow-up, and how many of any group were stable or were switched to any other one AZT: Azythromicin; DOXY: Doxycycline